Policy ForumAids

Promote HIV Chemoprophylaxis Research, Don't Prevent It

See allHide authors and affiliations

Science  30 Sep 2005:
Vol. 309, Issue 5744, pp. 2170-2171
DOI: 10.1126/science.1116204

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Preexposure chemoprophylaxis (PrEP) is a promising approach to HIV-1 prevention that warrants clinical evaluation, especially in regions of the world hit hardest by the epidemic. Controversy has arisen that highlights the needs of high-risk populations who frequently have limited access to information and medical care. The authors of this Policy Forum recommend involvement of community leaders and local investigators early in the development of research projects, open communication of accurate information about research, and active development of prevention and treatment infrastructure, which all serve to build the community trust that is the basis for research into finding ways to stop the spread of HIV/AIDS.